IL84343A - Pharmaceutical compositions containing spirapril and a calcium antagonist for treatment of hypertension and congestive heart failure - Google Patents

Pharmaceutical compositions containing spirapril and a calcium antagonist for treatment of hypertension and congestive heart failure

Info

Publication number
IL84343A
IL84343A IL84343A IL8434387A IL84343A IL 84343 A IL84343 A IL 84343A IL 84343 A IL84343 A IL 84343A IL 8434387 A IL8434387 A IL 8434387A IL 84343 A IL84343 A IL 84343A
Authority
IL
Israel
Prior art keywords
spirapril
hypertension
treatment
pharmaceutical compositions
heart failure
Prior art date
Application number
IL84343A
Other languages
English (en)
Other versions
IL84343A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL84343A0 publication Critical patent/IL84343A0/xx
Publication of IL84343A publication Critical patent/IL84343A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL84343A 1986-11-03 1987-11-02 Pharmaceutical compositions containing spirapril and a calcium antagonist for treatment of hypertension and congestive heart failure IL84343A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL84343A0 IL84343A0 (en) 1990-02-09
IL84343A true IL84343A (en) 1993-07-08

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84343A IL84343A (en) 1986-11-03 1987-11-02 Pharmaceutical compositions containing spirapril and a calcium antagonist for treatment of hypertension and congestive heart failure

Country Status (25)

Country Link
KR (1) KR960005145B1 (de)
AT (1) AT397343B (de)
AU (1) AU615883B2 (de)
BE (1) BE1002063A4 (de)
CA (1) CA1314222C (de)
CH (1) CH677189A5 (de)
DE (1) DE3736505A1 (de)
DK (1) DK574087A (de)
ES (1) ES2010524A6 (de)
FI (1) FI874823A (de)
FR (1) FR2605885B1 (de)
GR (1) GR871680B (de)
HK (1) HK138893A (de)
HU (1) HU199681B (de)
IE (1) IE60496B1 (de)
IL (1) IL84343A (de)
IT (1) IT1212037B (de)
LU (1) LU87034A1 (de)
MY (1) MY102124A (de)
NL (1) NL8702502A (de)
NO (1) NO874539L (de)
NZ (1) NZ222401A (de)
PH (1) PH23249A (de)
PT (1) PT86062B (de)
SE (1) SE8704272L (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
HUT47847A (en) 1989-04-28
GR871680B (en) 1988-05-02
FR2605885A1 (fr) 1988-05-06
NO874539L (no) 1988-05-04
FI874823A (fi) 1988-05-04
HU199681B (en) 1990-03-28
AU8057687A (en) 1988-05-05
PT86062B (pt) 1990-11-07
IL84343A0 (en) 1990-02-09
ES2010524A6 (es) 1989-11-16
KR960005145B1 (ko) 1996-04-22
CA1314222C (en) 1993-03-09
CH677189A5 (de) 1991-04-30
DK574087A (da) 1988-05-04
NZ222401A (en) 1991-04-26
ATA286987A (de) 1993-08-15
IE872951L (en) 1988-05-03
PH23249A (en) 1989-06-16
SE8704272D0 (sv) 1987-11-02
MY102124A (en) 1992-03-31
PT86062A (en) 1987-12-01
AU615883B2 (en) 1991-10-17
LU87034A1 (fr) 1988-05-03
IE60496B1 (en) 1994-07-27
IT1212037B (it) 1989-11-08
SE8704272L (sv) 1988-05-04
FR2605885B1 (fr) 1993-09-10
NO874539D0 (no) 1987-11-02
DK574087D0 (da) 1987-11-02
FI874823A0 (fi) 1987-11-02
BE1002063A4 (fr) 1990-06-12
IT8748553A0 (it) 1987-10-30
HK138893A (en) 1993-12-24
DE3736505A1 (de) 1988-05-05
NL8702502A (nl) 1988-06-01
AT397343B (de) 1994-03-25
KR880006197A (ko) 1988-07-22

Similar Documents

Publication Publication Date Title
IL82908A (en) Pharmaceutical compositions containing neutral metalloendopeptidase inhibitors for treatment of hypertension and their preparation
PT85531A (en) Process for the preparation of imidazole compounds and of a pharmaceutical compositions comprising the same
IL84054A (en) Pharmaceutical combination of angiotensin-converting enzyme inhibitors with calcium antagonists
HUT48458A (en) Composition for promoting dosage of pharmaceutical compositions
PH24749A (en) Piperidine compounds, pharmaceutical composition and method of use thereof
GB2208200B (en) Pharmaceutical compositions of somatostatin analogues
PH25430A (en) Pharmaceutical compositions containing calcium salts
EP0420930A4 (en) Method of synthesis and novel compounds for pharmaceutical uses
IL90639A (en) Neplanocin derivatives and analogs and pharmaceutical compositions containing them
IL88207A0 (en) Imidazole compounds and pharmaceutical compositions for the treatment of osteoporosis
IL84343A (en) Pharmaceutical compositions containing spirapril and a calcium antagonist for treatment of hypertension and congestive heart failure
HK8994A (en) Medicament for treatment of pregnancy-induced hypertension
ZA878658B (en) Substituted thienoimidazole-toluidine derivatives,a process for their preparation,pharmaceutical compositions containing them,and their use as inhibitors of gastric acid secretion
ZA887764B (en) Potentiation of antihypertensive effect of ace inhibitors
GB2220652B (en) Treatment of pastures
ZA878256B (en) Pharmaceutical composition for use against hypertension and congestive heart failure
CY1702A (en) Pharmaceutical composition for use against hypertension and congestive heart failure
PT85815A (en) Process for the preparation of a pharmaceutical compound for the treatment of high blood pressure containig as active ingredient a mixture of proline with a conversion inhibitor of the angiotensine enzyme and thiazide
GB8915315D0 (en) Pharmaceutical compositions for use against hypertension and congestive heart failure
SG115493G (en) Medicament for treatment of pregnancy-induced hypertension
GB8823283D0 (en) Pharmaceutical composition for use against hypertension & congestive heart failure
NZ220852A (en) N-(imidazolylmethyl)-diphenylazomethine derivatives and pharmaceutical compositions
IE882042L (en) Composition for treatment of pulmonary hypertension
GB8703235D0 (en) Compositions for treatment of cellulosic materials
RO94491B1 (ro) Produs medicamentos cu actiune hipotensiva

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed